BNY Mellon · VRTX Holdings Trend
Vertex Pharmaceuticals · SEC 13F
BNY Mellon Holdings of VRTX by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 1.9M | $784M | — |
| 2024Q2 | 2.1M | $869M | +10.8% |
| 2024Q3 | 2.0M | $838M | -3.6% |
| 2024Q4 | 2.0M | $721M | -13.9% |
| 2025Q1 | 1.9M | $836M | +16.0% |
| 2025Q2 | 1.8M | $720M | -13.9% |
| 2025Q3 | 1.8M | $620M | -13.9% |
| 2025Q4 | 1.8M | $697M | +12.5% |
| 2026Q1 | 1.8M | $711M | +2.0% |
← Back to VRTX holders ← Back to VRTX profile
Data source: SEC EDGAR Form 13F